Latent Labs Announces Latent-X2: AI-Generated Antibodies With Drug-Like Developability and Low Ex Vivo Immunogenicity – Business Wire

  1. Latent Labs Announces Latent-X2: AI-Generated Antibodies With Drug-Like Developability and Low Ex Vivo Immunogenicity  Business Wire
  2. Scientists make AI-driven breakthrough in fight against deadly diseases: ‘Will have significant positive impact’  

Continue Reading